Equity Overview
Price & Market Data
Price: $7.45
Daily Change: -$0.19 / 2.55%
Range: $7.32 - $7.78
Market Cap: $4,373,606
Volume: 32,697
Performance Metrics
1 Week: -16.37%
1 Month: -51.63%
3 Months: -98.49%
6 Months: -99.64%
1 Year: -99.71%
YTD: -99.42%
Company Details
Employees: 6
Sector: Technology services
Industry: Packaged software
Country: United States
Details
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN software application, a non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also develops NOCISCAN Post-Processor Suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.